Abstract | INTRODUCTION: MATERIALS AND METHODS: The AA used the schedule reported below to value the levels of PT and aPTT in the patient. Blood Collection: Venous blood from patient and control was collected in glass tubes for routine serum preparation and into plastic tubes (0.129 M sodium citrate, Becton-Dickinson Vacutainer Systems) in a ratio of blood to anticoagulant of 9:1. Platelet Poor Plasma (PPP) was obtained by centrifugation at 4.000 x g for 15 minutes at room temperature. The plasma was recentrifuged for another 10 min at 12000 g to fully eliminate platelet concentration. A normal control plasma pool was prepared by mixing equal volumes of platelet-free plasma obtained from at least 50 normal volunteers. Prothrombin time (PT) was measured with Recombiplastin (IL, Milano Italy). Activated partial thromboplastin times (APTT) was measured with APTT-SP (IL, Milano Italy). They were performed on the coagulation analyzer ACL 1000 (IL, Milano Italy). RESULTS: The results were interpreted from the ratio of the patient times to the normal control times (Table I). CONCLUSION:
|
Authors | Antonio Varricchio, Michela Schettino, Antonio Ciampa, Carlo Iannace, Domenico Lo Conte, Lorenzo Di Libero, Bernadette Donnarumma, Raffaella Vigorito, Mariolina Lepore |
Journal | Annali italiani di chirurgia
(Ann Ital Chir)
Vol. 85
Issue ePub
(Jun 25 2014)
ISSN: 2239-253X [Electronic] Italy |
PMID | 25204840
(Publication Type: Case Reports, Journal Article)
|
Chemical References |
- Recombinant Proteins
- recombinant FVIIa
- Factor VIIa
|
Topics |
- Breast Neoplasms
(complications, surgery)
- Factor VII Deficiency
(complications)
- Factor VIIa
(therapeutic use)
- Female
- Humans
- Middle Aged
- Paget's Disease, Mammary
(complications, surgery)
- Postoperative Hemorrhage
(etiology, prevention & control)
- Preoperative Care
- Recombinant Proteins
(therapeutic use)
|